CD8A and systemic sclerosis: Regarding the cellular immunity, the presence of specific HCMV antigen-driven CD8+ T cells has been observed in SSc patients [9]; an impaired NK response against HHV-6A/B was observed in a subset of SSc patients expressing KIR2DL2 receptor [10].